Cargando…

Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations

Detalles Bibliográficos
Autores principales: Mullan, Brian, Dravis, Bryan, Lim, Amareth, Clarke, Ambrose, Janes, Susan, Lambooy, Pete, Olson, Don, O’Riordan, Tomas, Ricart, Bruce, Tulloch, Alexander G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284901/
https://www.ncbi.nlm.nih.gov/pubmed/22373255
http://dx.doi.org/10.1186/1753-6561-5-S8-P110
_version_ 1782224414741364736
author Mullan, Brian
Dravis, Bryan
Lim, Amareth
Clarke, Ambrose
Janes, Susan
Lambooy, Pete
Olson, Don
O’Riordan, Tomas
Ricart, Bruce
Tulloch, Alexander G
author_facet Mullan, Brian
Dravis, Bryan
Lim, Amareth
Clarke, Ambrose
Janes, Susan
Lambooy, Pete
Olson, Don
O’Riordan, Tomas
Ricart, Bruce
Tulloch, Alexander G
author_sort Mullan, Brian
collection PubMed
description
format Online
Article
Text
id pubmed-3284901
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32849012012-02-23 Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations Mullan, Brian Dravis, Bryan Lim, Amareth Clarke, Ambrose Janes, Susan Lambooy, Pete Olson, Don O’Riordan, Tomas Ricart, Bruce Tulloch, Alexander G BMC Proc Meeting Abstract BioMed Central 2011-11-22 /pmc/articles/PMC3284901/ /pubmed/22373255 http://dx.doi.org/10.1186/1753-6561-5-S8-P110 Text en Copyright ©2011 Mullan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Mullan, Brian
Dravis, Bryan
Lim, Amareth
Clarke, Ambrose
Janes, Susan
Lambooy, Pete
Olson, Don
O’Riordan, Tomas
Ricart, Bruce
Tulloch, Alexander G
Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations
title Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations
title_full Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations
title_fullStr Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations
title_full_unstemmed Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations
title_short Disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations
title_sort disulphide bond reduction of a therapeutic monoclonal antibody during cell culture manufacturing operations
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284901/
https://www.ncbi.nlm.nih.gov/pubmed/22373255
http://dx.doi.org/10.1186/1753-6561-5-S8-P110
work_keys_str_mv AT mullanbrian disulphidebondreductionofatherapeuticmonoclonalantibodyduringcellculturemanufacturingoperations
AT dravisbryan disulphidebondreductionofatherapeuticmonoclonalantibodyduringcellculturemanufacturingoperations
AT limamareth disulphidebondreductionofatherapeuticmonoclonalantibodyduringcellculturemanufacturingoperations
AT clarkeambrose disulphidebondreductionofatherapeuticmonoclonalantibodyduringcellculturemanufacturingoperations
AT janessusan disulphidebondreductionofatherapeuticmonoclonalantibodyduringcellculturemanufacturingoperations
AT lambooypete disulphidebondreductionofatherapeuticmonoclonalantibodyduringcellculturemanufacturingoperations
AT olsondon disulphidebondreductionofatherapeuticmonoclonalantibodyduringcellculturemanufacturingoperations
AT oriordantomas disulphidebondreductionofatherapeuticmonoclonalantibodyduringcellculturemanufacturingoperations
AT ricartbruce disulphidebondreductionofatherapeuticmonoclonalantibodyduringcellculturemanufacturingoperations
AT tullochalexanderg disulphidebondreductionofatherapeuticmonoclonalantibodyduringcellculturemanufacturingoperations